GlyCosmos Portal

GlyCosmos PubAnnotations

Recent publication annotations of glycans, cell types, and proteins, from PubAnnotation.

Displaying entries **9601 - 9625** of **24862** in total

« First

‹ Prev

…

381

382

383

384

385

386

387

388

389

…

Next ›

Last »
Title ▲	Authors	PubMed ID	Source	Publication Year
Heparin oligosaccharide sequence and size essential for inhibition of pulmonary artery smooth muscle cell proliferation.	Garg HG Cindhuchao N Quinn DA Hales CA Thanawiroon C Capila I Linhardt RJ	12433502	Carbohydr Res	2002
Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus.	Ziarek JJ Veldkamp CT Zhang F Murray NJ Kartz GA Liang X Su J Baker JE Linhardt RJ Volkman BF	23148226	J Biol Chem	2013
Heparin potentiates Avastin-mediated inhibition of VEGF binding to fibronectin and rescues Avastin activity at acidic pH.	Tsiros D Sheehy CE Pecchia S Nugent MA	31601651	J Biol Chem	2019
Heparin potentiates in vivo neutrophil migration induced by IL-8.	Dias-Baruffi M Pereira-da-Silva G Jamur MC Roque-Barreira MC	9881755	Glycoconj J	1998
Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2.	Zhao B Katagiri T Toyoda H Takada T Yanai T Fukuda T Chung UI Koike T Takaoka K Kamijo R	16754660	J Biol Chem	2006
Heparin prevents intracellular hyaluronan synthesis and autophagy responses in hyperglycemic dividing mesangial cells and activates synthesis of an extensive extracellular monocyte-adhesive hyaluronan matrix after completing cell division.	Wang A Ren J Wang CP Hascall VC	24482224	J Biol Chem	2014
Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle.	Reilly CF Kindy MS Brown KE Rosenberg RD Sonenshein GE	2651437	J Biol Chem	1989
Heparin promotes fibrillation of most phenol-soluble modulin virulence peptides from Staphylococcus aureus.	Najarzadeh Z Zaman M Sereikaite V Strømgaard K Andreasen M Otzen DE	34270957	J Biol Chem	2021
Heparin promotes proteolytic inactivation by thrombin of a reactive site mutant (L444R) of recombinant heparin cofactor II.	Ciaccia AV Willemze AJ Church FC	8995378	J Biol Chem	1997
Heparin promotes the binding of thrombin to fibrin polymer. Quantitative characterization of a thrombin-fibrin polymer-heparin ternary complex.	Hogg PJ Jackson CM	2294104	J Biol Chem	1990
Heparin protects cathepsin G against inhibition by protein proteinase inhibitors.	Ermolieff J Boudier C Laine A Meyer B Bieth JG	7961933	J Biol Chem	1994
Heparin regulates vascular endothelial growth factor165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells. Comparison of the effects of heparin and modified heparins.	Ashikari-Hada S Habuchi H Kariya Y Kimata K	16027124	J Biol Chem	2005
Heparin selectively inhibits the transcription of tissue-type plasminogen activator in primate arterial smooth muscle cells during mitogenesis.	Au YP Kenagy RD Clowes AW	1310687	J Biol Chem	1992
Heparin sequencing.	Stringer SE Kandola BS Pye DA Gallagher JT	12626406	Glycobiology	2003
Heparin strongly decreases the rate of inhibition of neutrophil elastase by alpha 1-proteinase inhibitor.	Frommherz KJ Faller B Bieth JG	1869557	J Biol Chem	1991
Heparin strongly enhances the formation of beta2-microglobulin amyloid fibrils in the presence of type I collagen.	Relini A De Stefano S Torrassa S Cavalleri O Rolandi R Gliozzi A Giorgetti S Raimondi S Marchese L Verga L Rossi A Stoppini M Bellotti V	18056266	J Biol Chem	2008
Heparin suppresses specific second messenger pathways for protooncogene expression in rat vascular smooth muscle cells.	Pukac LA Ottlinger ME Karnovsky MJ	1371276	J Biol Chem	1992
Heparin synergistically enhances interleukin-11 signaling through up-regulation of the MAPK pathway.	Rajgopal R Butcher M Weitz JI Shaughnessy SG	16720575	J Biol Chem	2006
Heparin trisaccharides with nonreducing 2-amino-2-deoxy-alpha-D-glucopyranosyl end-groups suitable as substrates for catabolic enzymes.	Weissmann B Chao H	3791294	Carbohydr Res	1986
Heparin type IV collagen interactions: equilibrium binding and inhibition of type IV collagen self-assembly.	Tsilibary EC Koliakos GG Charonis AS Vogel AM Reger LA Furcht LT	3198614	J Biol Chem	1988
Heparin with two binding sites for antithrombin or platelet factor 4.	Jordan RE Favreau LV Braswell EH Rosenberg RD	7053378	J Biol Chem	1982
Heparin, carboxyl-reduced sulfated heparin, and Trestatin A sulfate. Antiproliferative and anticoagulant activities.	Wessel HP Hosang M Tschopp TB Weimann BJ	2279243	Carbohydr Res	1990
Heparin, heparan sulfate, and dermatan sulfate regulate formation of the insulin-like growth factor-I and insulin-like growth factor-binding protein complexes.	Arai T Parker A Busby W Jr Clemmons DR	7519608	J Biol Chem	1994
Heparin, sulfated heparinoids, and lipoteichoic acids bind to the 70-kDa peptidoglycan/lipopolysaccharide receptor protein on lymphocytes.	Dziarski R Gupta D	8294463	J Biol Chem	1994
Heparin-binding epidermal growth factor-like growth factor expression in cultured fetal human vascular smooth muscle cells. Induction of mRNA levels and secretion of active mitogen.	Dluz SM Higashiyama S Damm D Abraham JA Klagsbrun M	8349708	J Biol Chem	1993

Download data in CSV format Download data in TSV format Download data in JSON format

Table Filtering

GlyTouCan

GlyComb

GlycoPOST

UniCarb-DR

All Resources

Other Information

Tools

Search Tools

International Collaboration

Acknowledgements